Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Jeppe Øvli Øvlesen — CEO

Roles

SynAct Pharma AB Stockholm
CEO
05.03.2026 – 05.03.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
05.03.2026SynAct Pharma AB Stockholm
Bought — open marketAcquisition
via Quantass ApS
7,900SEK 17.99
SEK 142,145.58
↗